Literature DB >> 12223281

Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system.

Jinhua Lu1, Cathleen Teh, Uday Kishore, Kenneth B M Reid.   

Abstract

Collectins and ficolins represent two important groups of pattern recognition molecules, which bind to oligosaccharide structures on the surface of microorganisms, leading to the killing of bound microbes through complement activation and phagocytosis. Collectins and ficolins bear no significant sequence homology except for the presence of collagen-like sequences over the N-terminal halves of the polypeptides that enable the assembly of these molecules into oligomeric structures. Collectins and ficolins both contain lectin activities within the C-terminal halves of their polypeptides, the C-type carbohydrate recognition domain (CRDs) and fibrinogen beta/gamma (homology) (FBG) domain, respectively. These domains form trimeric clusters at the ends of the collagen triple helices emanating from a central hub, where the N-terminal ends of the polypeptides merge. The collectins and ficolins seem to have evolved to recognize the surface sugar codes of microbes and their binding, to these arrays of cell surface carbohydrate molecules, targets the microbe for subsequent clearance by phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223281     DOI: 10.1016/s0304-4165(02)00320-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  61 in total

Review 1.  Plant lectins: occurrence, biochemistry, functions and applications.

Authors:  H Rüdiger; H J Gabius
Journal:  Glycoconj J       Date:  2001-08       Impact factor: 2.916

2.  Suitability of binary mixtures of water with aprotic solvents to turn hydroxyl protons of carbohydrate ligands into conformational sensors in NOE and transferred NOE experiments.

Authors:  Hans-Christian Siebert; Sabine André; Johannes F G Vliegenthart; Hans-Joachim Gabius; Michael J Minch
Journal:  J Biomol NMR       Date:  2003-03       Impact factor: 2.835

Review 3.  Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement.

Authors:  S P Hart; J R Smith; I Dransfield
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

4.  Collagen Mimetic Peptides: Progress Towards Functional Applications.

Authors:  S Michael Yu; Yang Li; Daniel Kim
Journal:  Soft Matter       Date:  2011-09-21       Impact factor: 3.679

5.  Identification of complement regulatory domains in vaccinia virus complement control protein.

Authors:  Jayati Mullick; John Bernet; Yogesh Panse; Sharanabasava Hallihosur; Akhilesh K Singh; Arvind Sahu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.

Authors:  Geoffrey W Stone; Suzanne Barzee; Victoria Snarsky; Kristin Kee; Celsa A Spina; Xiao-Fang Yu; Richard S Kornbluth
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens.

Authors:  Hany Sahly; Yona Keisari; Erika Crouch; Nathan Sharon; Itzhak Ofek
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

8.  Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.

Authors:  J K van de Wetering; F E J Coenjaerts; A B Vaandrager; L M G van Golde; J J Batenburg
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 9.  C-type lectins and phagocytosis.

Authors:  Ann M Kerrigan; Gordon D Brown
Journal:  Immunobiology       Date:  2009-03-03       Impact factor: 3.144

10.  Structural characterisation of ligand-binding determinants in human lung surfactant protein D: influence of Asp325.

Authors:  A K Shrive; C Martin; I Burns; J M Paterson; J D Martin; J P Townsend; P Waters; H W Clark; U Kishore; K B M Reid; T J Greenhough
Journal:  J Mol Biol       Date:  2009-09-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.